Search details
1.
A single-cell map of antisense oligonucleotide activity in the brain.
Nucleic Acids Res
; 51(14): 7109-7124, 2023 08 11.
Article
in English
| MEDLINE | ID: mdl-37188501
2.
Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease.
J Virol
; 97(2): e0167222, 2023 02 28.
Article
in English
| MEDLINE | ID: mdl-36651748
3.
Analysis of non-human primate models for evaluating prion disease therapeutic efficacy.
PLoS Pathog
; 18(8): e1010728, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35994510
4.
Genetic counseling for prion disease: Updates and best practices.
Genet Med
; 24(10): 1993-2003, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35819418
5.
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints.
Nucleic Acids Res
; 48(19): 10615-10631, 2020 11 04.
Article
in English
| MEDLINE | ID: mdl-32776089
6.
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.
Proc Natl Acad Sci U S A
; 116(16): 7793-7798, 2019 04 16.
Article
in English
| MEDLINE | ID: mdl-30936307
7.
Multimodal small-molecule screening for human prion protein binders.
J Biol Chem
; 295(39): 13516-13531, 2020 09 25.
Article
in English
| MEDLINE | ID: mdl-32723867
8.
Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.
Mol Cell Proteomics
; 18(12): 2388-2400, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31558565
9.
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
BMC Med
; 18(1): 140, 2020 06 18.
Article
in English
| MEDLINE | ID: mdl-32552681
10.
Where have prions been all our lives?
Brain
; 146(6): 2206-2207, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-37161596
11.
The Patient-Scientist's Mandate.
N Engl J Med
; 382(2): 107-109, 2020 Jan 09.
Article
in English
| MEDLINE | ID: mdl-31914240
12.
Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation.
Hum Mol Genet
; 24(9): 2442-57, 2015 May 01.
Article
in English
| MEDLINE | ID: mdl-25574027
13.
Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarker.
medRxiv
; 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38746398
14.
Modulation of prion protein expression through cryptic splice site manipulation.
bioRxiv
; 2023 Dec 19.
Article
in English
| MEDLINE | ID: mdl-38187635
15.
A single-cell map of antisense oligonucleotide activity in the brain.
bioRxiv
; 2023 Feb 14.
Article
in English
| MEDLINE | ID: mdl-36824749
16.
Biomarker changes preceding symptom onset in genetic prion disease.
medRxiv
; 2023 Dec 18.
Article
in English
| MEDLINE | ID: mdl-38196583
17.
Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials.
Sci Rep
; 12(1): 17708, 2022 10 21.
Article
in English
| MEDLINE | ID: mdl-36271285
18.
Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS.
JCI Insight
; 7(6)2022 03 22.
Article
in English
| MEDLINE | ID: mdl-35133987
19.
Novel quaternary structures of the human prion protein globular domain.
Biochimie
; 191: 118-125, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34517052
20.
Towards a treatment for genetic prion disease: trials and biomarkers.
Lancet Neurol
; 19(4): 361-368, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32199098